New Delhi, Apr 23 (PTI) Biotechnology firm Biocon on Wednesday said its board has approved raising up to Rs 4,500 crore through issue of securities.

The company's board has approved to raise the capital by way of issuance any instrument or security, including shares, non-convertible debt instruments along with warrants or any other convertible securities by way of qualified institutions placement or rights issue etc, Biocon said in a regulatory filing.

Also Read | Rules Changing From May 1: ATM Withdrawal, Bank Balance Check To Cost More As Hiked Interchange Fees Come Into Effect Next Month; Minimum Balance Rules, Credit Card Benefits Also Revised by Major Banks.

The company plans "issuance of securities up to an aggregate amount of Rs 4,500 crore, in one or more tranches and/or by way of one or more issuances", it said.

Biocon shares on Wednesday ended 0.57 per cent up at Rs 335.85 apiece on BSE.

Also Read | EPFO Pension Hike: Here's How Much Pensioners Could See in Revised Monthly Payments As Government Considers 650% Hike.

(The above story is verified and authored by Press Trust of India (PTI) staff. PTI, India’s premier news agency, employs more than 400 journalists and 500 stringers to cover almost every district and small town in India.. The views appearing in the above post do not reflect the opinions of LatestLY)